Cargando…
Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen‐allergic patients with apple allergy
It is still unclear whether allergen‐specific immunotherapy (AIT) with birch pollen improves birch pollen‐related food allergy. One reason for this may be the lack of standardized tests to assess clinical reactions to birch pollen‐related foods, for example apple. We tested the applicability of reco...
Autores principales: | Kinaciyan, T., Nagl, B., Faustmann, S., Kopp, S., Wolkersdorfer, M., Bohle, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722287/ https://www.ncbi.nlm.nih.gov/pubmed/26443126 http://dx.doi.org/10.1111/all.12781 |
Ejemplares similares
-
The Effect of Birch Pollen Immunotherapy on Apple and rMal d 1 Challenges in Adults with Apple Allergy
por: van der Valk, Johanna, et al.
Publicado: (2020) -
Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response
por: Kitzmüller, Claudia, et al.
Publicado: (2019) -
Identification of apple cultivars hypoallergenic for birch pollen‐allergic individuals by a multidisciplinary in vitro and in vivo approach
por: Strobl, Maria R., et al.
Publicado: (2022) -
The Incidence of Delayed-Type Hypersensitivity Reactions to Apples Among Patients Allergic to Birch Pollen
por: Wagner, Aneta, et al.
Publicado: (2018) -
Allergen‐specific immunotherapy with apples: selected cultivars could be a promising tool for birch pollen allergy
por: Nothegger, B., et al.
Publicado: (2020)